University of Calgary
University of Calgary
Calgary, Alberta, Canada10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance | Aneurysm, Aneurysm, Ascending Aorta, aortic aneurysm, aortic disorder, cardiovascular disorder, thoracic aortic aneurysm, vascular disorder | Recruiting | Not applicable | 2026-09-28 | NCT03536312 | |
| Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells | neoplasm | Recruiting | Phase 2 / Phase 3 | 2026-09-18 | NCT03435796 | |
| Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension | cardiovascular disorder, hypertensive disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-09-10 | NCT01471834 | |
| Treatment of Persisting Symptoms After Concussion With Psilocybin Assisted Therapy | Brain Concussion, Brain Injuries, Traumatic, Craniocerebral Trauma, Head Injuries, Closed, Wounds, Nonpenetrating, brain disorder, brain injury, central nervous system disorder, injury, nervous system disorder, nervous system injury | Recruiting | Phase 1 | 2026-09-09 | NCT06615908 | |
| Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence | Stress Disorders, Traumatic, acute stress disorder, combat disorder, psychiatric disorder | Not yet recruiting | Phase 2 | 2026-09-08 | NCT06885996 | |
| Analgesic Efficacy of Surgeon-administered Transversus Abdominis Plane Blocks for Caesarean Section. | Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms | Recruiting | Not applicable | 2026-06-15 | NCT06324942 | |
| Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D) | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Recruiting | Phase 4 | 2026-06-11 | NCT05017311 | |
| Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy | Arrhythmias, Cardiac, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Death, Death, Sudden, Death, Sudden, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arrhythmogenic right ventricular cardiomyopathy, cardiac arrest, cardiomyopathy, cardiovascular disorder, congenital heart disease, heart disorder | Recruiting | Phase 2 | 2026-03-12 | NCT06174220 | |
| The Alberta BLOOM Premature Child Study | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Infant, Newborn, Diseases, Infant, Premature, Diseases, Respiratory Hypersensitivity, allergic disease, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Enrolling by invitation | Not stated | 2024-12-24 | NCT05011071 | |
| HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy | aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, heart disorder, heart valve disorder, hypertrophic cardiomyopathy, subvalvular aortic stenosis | Active, not recruiting | Not stated | 2024-12-13 | NCT01915615 |